Study
Study finds that seniors with chronic kidney disease have a higher risk of hearing loss.
In plain language
Recent research has found that older adults with chronic kidney disease (CKD) are more likely to experience hearing loss. This study, which analyzed data from the National Health and Nutrition Examination Survey (NHANES), showed that individuals with CKD were significantly more at risk for hearing loss compared to those without CKD. This is important because hearing loss can greatly impact quality of life, making it difficult to communicate and engage with others, potentially leading to feelings of isolation. Seniors with CKD should be aware of this increased risk and discuss hearing health with their healthcare providers.
Use the full description to understand the study design, methods, and the limits of the findings.
This study investigates the connections between auditory symptoms and kidney disease. Researchers analyzed hearing loss and tinnitus prevalence in chronic kidney disease patients, exploring shared pathophysiological mechanisms and implications for comprehensive patient care.
Open the original publication for the complete methods, outcomes, and source material.
Published October 2025
Opens at the publisher · external site · may require institutional access
The study provides valuable insights into the association between hearing loss, tinnitus, and chronic kidney disease using NHANES data. However, as a cross-sectional study, it cannot establish causality. The study is well-documented and transparent, with appropriate statistical methods, but lacks external validation.
| Category | Score | Rating |
|---|---|---|
| Study Design / Evidence Level | 6.5/10 | |
| Bias & Methods | 6.0/10 | |
| Statistical Integrity | 7.0/10 | |
| Transparency | 8.0/10 | |
| Conflict of Interest Disclosure | 9.0/10 | |
| Replication / External Validation | 5.0/10 | |
| Relevance to Seniors | 8.0/10 | |
| Journal Quality | 8.0/10 |
The study's cross-sectional design limits causal conclusions, and future research should aim for longitudinal or experimental designs to strengthen evidence.
Build a personalized plan using research-backed studies, conditions, and treatments.